Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies? (2021)
Attributed to:
EnCRISPrx - A Permanent CRISPR-based Approach To Rescue Dravet Syndrome By Enhancing Scn1a Promoter Activity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s13311-021-01081-y
PubMed Identifier: 34235638
Publication URI: http://europepmc.org/abstract/MED/34235638
Type: Journal Article/Review
Volume: 18
Parent Publication: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Issue: 3
ISSN: 1878-7479